On Monday, November 16, 2020, the Company, Moderna, Inc., MRNA stock construct a change of 9.58 percent (Gain) in a total of its share price and having its trading value $97.95, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $38.08B with the total Outstanding Shares of 394.68M.
P/S, P/E, P/B & P/C values of (NASDAQ: MRNA):
Moderna, Inc. institutional ownership is standing at 55.8 percent, while insider ownership is 2.4 percent. As of now, MRNA has a P/S, P/E and, P/B values of 154.34, 0, and 14.01 respectively. Its P/Cash is valued at 11.62.
The stock SMA50 is now at 39.13 percent. In looking, the SMA 200 we see that the stock has seen a 74.05 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.
Looking into the profitability ratios of MRNA stock, an investor will find its ROE, ROA, ROI standing at -28.1 percent, -20.3 percent and, -44.9 percent, respectively.
A beta factor is used to measure the volatility of the stock. The stock remaining at 8.27 percent volatile for the week and 5.88 percent for the month.
Gross / Operating Margins of MRNA:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Moderna, Inc. recorded it at $94.79.
Historical Performance In The News:
Taking a look at the performance of Moderna, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 26 percent, resulting in a performance for the month at 32.47 percent.
Therefore, the stated figure displays a quarterly performance of 46.13 percent, bringing six-month performance to 36.67 percent and year to date performance of 400.77 percent. As of now, Moderna, Inc. has a P/S, P/E and, P/B values of 154.34, 0, and 14.01 respectively. Its P/Cash is valued at 11.62.
Earnings per Share Details of Moderna, Inc.:
The EPS of MRNA is strolling at -1.62, measuring its EPS growth this year at -27.1 percent. As a result, the company has an EPS growth of 214 percent for the approaching year.